Quantification of erythrocyte aggregation by blood echogenicity: a preliminary study.
Many techniques were proposed to assess erythrocyte aggregation in clinical and experimental investigations in view of in vitro determination. However no methodology until now is available to measure erythrocyte aggregation in flowing blood in vivo. High resolution ultrasonography provides an original way to quantify erythrocyte aggregation using the echogenicity of blood. We have developed and A-mode ultrasound scanner coupled with an oscilloscope and a computer allowing the analysis of ultrasonic signals produced by erythrocytes. A closed measurement chamber connected to a calibrated roller-type blood pump where blood was perfused was used. The echogenicity of blood was determined at different shear rates. Dextran, fibrinogen and other high molecular weight substances were added to increase erythrocyte aggregation. Changes in red blood concentration was also tested. An increase in blood echogenicity rate was observed at low shear. At a given shear rate blood echogenicity increased when fibrinogen or dextran were added. Such determination of the echogenicity of flowing blood in vitro will provide an approach to the quantification of erythrocyte aggregation in vivo circulation, especially in the veins where low shear rates are observed.
Razavian
S M
SM
Unité INSERM U28, Hôpital Broussais, Paris, France.
Levenson
J
J
Peronneau
P
P
Simon
A
A
D001696:Biomechanical Phenomena; D001769:Blood / Q000000981:diagnostic imaging*; D003911:Dextrans / Q000494:pharmacology; D004903:Erythrocyte Aggregation / Q000187:drug effects; D005340:Fibrinogen / Q000494:pharmacology; D006801:Humans; D008970:Molecular Weight; D010477:Perfusion; D012815:Signal Processing, Computer-Assisted; D014463:Ultrasonography / Q000295:instrumentation; D014680:Veins / Q000502:physiology
D003911:Dextrans; D005340:Fibrinogen